Clinical translation of immunomodulatory therapeutics-Reference-Cited by-同舟云学术

Clinical translation of immunomodulatory therapeutics

Published:2021-09 Issue: Volume:176 Page:113896
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Nash Amanda,Aghlara-Fotovat Samira,Hernandez Andrea,Scull Christopher,Veiseh Omid

Funder

Cancer Prevention and Research Institute of Texas

National Science Foundation

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference274 articles.

1. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010

2. Keytruda (Pembrolizumab): First PD-1 Inhibitor Approved for Previously Treated Unresectable or Metastatic Melanoma;Raedler;Am Health Drug Benefits,2015

3. Daratumumab: First Global Approval;McKeage;Drugs,2016

4. FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia;O'Leary;Clin Cancer Res,2019

5. Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma;Mian;Expert Opin Biol Ther,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-assembling peptides as immunomodulatory biomaterials;Frontiers in Bioengineering and Biotechnology;2023-03-01

2. Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches;Drug Delivery and Translational Research;2023-02-10

3. Applications of Extracellular Vesicles in Nervous System Disorders: An Overview of Recent Advances;Bioengineering;2022-12-30

4. Emerging tools and targets for immune engineering and modulation;Advanced Drug Delivery Reviews;2022-12

5. Exosomes as CNS Drug Delivery Tools and Their Applications;Pharmaceutics;2022-10-21